Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine PK in Pediatric Depression/Anxiety
NCT01491035Phase 2Completed
- Sponsor
- Lundbeck
- Start
- Apr 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vortioxetine in major depressive disorder (MDD), anxiety disorder, sponsored by Lundbeck. Started Apr 2012; status: completed.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT01491035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491035.